Labour set for biggest election victory in party history, poll suggests June 3, 2024 Labour is on course for the biggest election victory in the party’s history, surpassing Tony Blair’s 1997 landslide, a poll has suggested.
‘I’ve changed my mind’: Nigel Farage will stand in the General Election – and lead Reform June 3, 2024 “I’ve changed my mind. It’s allowed you know, it’s not always a sign of weakness. It could potentially be a sign of strength.
Former Melrose bosses take chunk of £180m bonus scheme June 3, 2024 Three former bosses at Melrose Industries have raked in a big chunk of a £180m bonus scheme shortly after leaving the group.
Marks and Spencer chief’s pay soars to decade high as turnaround pays off June 3, 2024 Marks and Spencer's turnaround plan has generated huge rewards for its boss, Stuart Machin.
Panmure Liberum to cut dozens of jobs after landmark City merger June 3, 2024 Newly-formed investment bank Panmure Liberum is planning to cut more than two dozen jobs after a merger between two of the City's leading brokers earlier this year.
Has sterling finally recovered from the impact of Brexit? June 3, 2024 A recovering economy is more likely to receive overseas investment, strengthening the pound.
TGI Fridays owner Hostmore shutters another cocktail bar amid sales slump June 3, 2024 TGI Friday's owner Hostmore said sales fell this year and confirmed the closure of another cocktail bar just three years after its launch.
Stealth tax raid to cost City workers £14k each by 2028 June 3, 2024 "The tax rises that happened as a result of the pandemic and the energy shock – these two giant shocks – will stay for their allotted time period," Hunt told the BBC.
Top London film studio behind Whitney Houston biopic secures multi-million pound injection June 3, 2024 Next month, Dimension will officially open the doors to a new virtual production complex in West London.
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial ruling June 3, 2024 GSK has hit back against a US ruling that found it could be sued over the potential cancer-causing properties of its heartburn drug Zantac.
